MedCap AB (publ) (STO:MCAP)

MedCap AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	286.3	370.4	370.1	188.2	236.2	139.7
Cash & Short-Term Investments	286.3	370.4	370.1	188.2	236.2	139.7
Cash Growth	-14.56%	0.08%	96.65%	-20.32%	69.08%	-4.64%
Accounts Receivable	324.5	267.3	210.6	237	169.3	137.9
Other Receivables	111.5	52.9	41	47.4	155.6	33.2
Receivables	436	320.2	251.6	284.4	324.9	171.1
Inventory	298.3	271.4	268.9	276.7	162.7	150.2
Prepaid Expenses	-	9.2	8.6	6.5	4.6	5.4
Other Current Assets	-	20.2	18.2	9.4	13.5	8.5
Total Current Assets	1,021	991.4	917.4	765.2	741.9	474.9
Property, Plant & Equipment	374.9	379.2	402.8	243.9	242.6	253.8
Goodwill	824.6	662.7	362.2	339.9	242.6	229.5
Other Intangible Assets	547.5	455.4	242.6	261.5	154.4	172
Long-Term Deferred Tax Assets	7.6	5.1	3.6	3.4	3.1	2.7
Long-Term Deferred Charges	-	110.9	62.2	47.8	44.5	36.3
Other Long-Term Assets	1.5	1.3	0.6	0.5	0.2	0.3
Total Assets	2,777	2,606	1,991	1,662	1,429	1,170

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	384.3	107.9	72.7	90.6	75.8	50
Accrued Expenses	-	80.2	75.8	77.1	42.7	42.8
Short-Term Debt	-	-	-	17.9	46.2	43.7
Current Portion of Long-Term Debt	43.4	59.3	25.2	24.1	42	23.3
Current Portion of Leases	44.2	42.9	35.4	27	27.9	24.5
Current Income Taxes Payable	76.3	41.5	42.1	46.7	21	10.1
Current Unearned Revenue	-	1.8	2.7	1.2	0.1	0.3
Other Current Liabilities	-	160.7	77.6	58.4	46.4	47.2
Total Current Liabilities	548.2	494.3	331.5	343	302.1	241.9
Long-Term Debt	162.1	156.6	48.8	72	96	18.3
Long-Term Leases	207.9	224.1	248.6	120.2	127.9	147.1
Long-Term Deferred Tax Liabilities	109.4	113.1	62.1	66.7	39	38.1
Other Long-Term Liabilities	161.3	159	12.2	33.2	5.6	26.4
Total Liabilities	1,189	1,147	703.2	635.1	570.6	471.8

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1,586	6	6	5.9	5.9	5.9
Additional Paid-In Capital	-	492.3	464	428.2	428.2	428.2
Retained Earnings	-	978.3	783.6	576	402	262.2
Comprehensive Income & Other	-	-24.5	28.4	12.8	20.2	-0.3
Total Common Equity	1,586	1,452	1,282	1,023	856.3	696
Minority Interest	1.7	6.8	6.2	4.2	2.4	1.7
Shareholders' Equity	1,588	1,459	1,288	1,027	858.7	697.7
Total Liabilities & Equity	2,777	2,606	1,991	1,662	1,429	1,170

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	457.6	482.9	358	261.2	340	256.9
Net Cash (Debt)	-171.3	-112.5	12.1	-73	-103.8	-117.2
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-11.43	-7.50	0.81	-4.91	-7.01	-7.92
Filing Date Shares Outstanding	14.98	15.02	14.97	14.81	14.81	14.81
Total Common Shares Outstanding	14.98	15.02	14.97	14.81	14.81	14.81
Working Capital	472.4	497.1	585.9	422.2	439.8	233
Book Value Per Share	105.91	96.68	85.62	69.08	57.83	47.00
Tangible Book Value	214	334	677.2	421.5	459.3	294.5
Tangible Book Value Per Share	14.29	22.24	45.23	28.47	31.02	19.89
Machinery	-	357.2	344.7	295	246.4	216.3

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 11, 2026

Data Sources Report a data error